# The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

> **NCT03837561** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 136 (actual)

## Conditions studied

- Glabellar Frown Lines

## Interventions

- **DRUG:** Cunox
- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT03837561
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-13
- **Primary completion:** 2019-03-12
- **Final completion:** 2019-06-03
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03837561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03837561, "The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03837561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*